TrialDiabetes care2023

Low-Dose Empagliflozin as Adjunct to Hybrid Closed-Loop Insulin Therapy in Adults With Suboptimally Controlled Type 1 Diabetes: A Randomized Crossover Controlled Trial.

Melissa-Rosina Pasqua et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.